SOPHiA GENETICS (SOPH) Short term Debt (2020)

SOPHiA GENETICS (SOPH) posted Short term Debt of $2.9 million for Q4 2020.

SOPHiA GENETICS (SOPH) Short term Debt (2020) Analysis & Trends

SOPHiA GENETICS has reported Short term Debt for 1 years, with the latest figure at $2.9 million in Q4 2020.

  • Quarterly Short term Debt changed N/A year-over-year to $2.9 million in Q4 2020, while the trailing twelve-month figure through Dec 2020 was $2.9 million (changed N/A YoY) and the FY2020 annual result came in at $2.9 million, changed N/A from the prior year.
  • Short term Debt held at $2.9 million in Q4 2020 per SOPH's latest filing.
  • Over five years, Short term Debt peaked at $2.9 million in Q4 2020 and troughed at $2.9 million in Q4 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Veeva Systems 39.72 Bn 32.40 Bn 662.02 Mn
2 BrightSpring Health Services 12.19 Bn 11.64 Bn 492.75 Mn
3 Healthequity 8.79 Bn 8.52 Bn 256.31 Mn
4 10x Genomics 7.31 Bn 6.76 Bn 112.50 Mn
5 Hinge Health 7.10 Bn 6.71 Bn 183.95 Mn
6 MiniMed 5.66 Bn 5.36 Bn 480.00 Mn
7 Waystar Holding 4.76 Bn 4.56 Bn 221.99 Mn
8 Doximity 4.46 Bn 3.77 Bn 132.93 Mn
9 Heartflow 3.66 Bn 3.28 Bn 53.19 Mn
10 SOPHiA GENETICS 553.79 Mn 446.12 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2020 2.87 Mn